Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. - Wikidata - awgldk - TriplyDB

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

http://www.wikidata.org/entity/Q44259982

about

Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Lung cancer signatures in plasma based on proteome profiling of mouse tumor models Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis Models of breast cancer: quo vadis, animal modeling?Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.Peptide aptamers: recent developments for cancer therapy.Computational expression deconvolution in a complex mammalian organ Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer.Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression.Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer.Tumor reversion: correction of malignant behavior by microenvironmental cues Molecular genetics of prostate cancer: new prospects for old challenges Oncogenes and tumor suppressor genes LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms.Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice.Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer.Generation of a novel MMTV-tTA transgenic mouse strain for the targeted expression of genes in the embryonic and postnatal mammary gland The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis Harnessing preclinical mouse models to inform human clinical cancer trials.Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.Mouse models of breast cancer metastasis.The HER family and cancer: emerging molecular mechanisms and therapeutic targets.Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.

P2860

Q22000765-75AAA1B7-0A74-4CB6-A95F-012B1C38EB74 Q24561953-521A29EB-107F-428E-AC62-1AF445FDA233 Q24628852-64F33E49-0363-4B10-99CA-EFB7E570743A Q24633878-911D2A70-6146-4F60-A1F2-67AD796A3829 Q24801345-F2DBE9D0-DDA4-4AFF-A094-38BF4A770637 Q24801681-6E0212A0-19E7-4974-847C-70F06B6D18F8 Q24803741-0EEC6F8F-C9BD-42F3-BF1D-112C8733E378 Q24803965-EE3E5C5A-3772-430E-8E4A-AFC3B9E92748 Q27340972-226861C5-02CD-4192-8CA7-EA5D535B455E Q28250940-23CEC6CE-807F-44D5-8C5F-81974D6D8377 Q33208592-DD181BF2-DC7D-4B8A-BE21-70C6554234B0 Q33216999-C48A14F3-9A11-4D9E-9AE6-A9BA928B7B44 Q33248722-80868780-0A81-4592-80D7-BD28C9A56A0B Q33304984-C6C997BD-85A7-4A80-9142-061262DE721D Q33332189-33667FFC-A1A4-4B74-AAED-DC9AC9E68157 Q33482643-F24FE3EB-F776-4850-A080-50228FA958BD Q33635061-F1E44F80-427F-4B15-8D0A-4AE9C3E9376F Q33763727-6965E314-66E4-4235-AB56-C728FAA95B95 Q33802624-231F97B9-7C9D-45D3-974E-4EAD30275AEB Q33866783-2051D12D-3818-44F4-8EC8-B64C5A55960B Q33887610-C405D189-E18D-435B-A7AD-4F6F1575D5F1 Q34002116-A81FE785-ABDC-4083-925B-954B04F920C8 Q34049857-40CAD0FC-8E6E-40FA-99A8-E468DB4A211D Q34102216-84E18884-71BA-44A4-A024-B1122F376562 Q34103266-5D7A9544-B9BF-466C-8E15-4F5225400F99 Q34127462-B0B1F13B-1176-4523-8FD2-316590B79FF3 Q34149922-29243757-3FF4-4701-AB80-DD5CDF07D326 Q34220979-5D99E3A1-8698-4FD8-81C8-5BD951416EDA Q34248882-4131BB06-4F26-4BCB-B0AB-A9FA6D9BD96B Q34286291-71707CC8-A1DA-4D38-8643-8ECFAED69639 Q34323926-949F5AA3-8A56-499E-B475-1D9D4252F7FD Q34405588-89532759-85FB-468B-A2EB-86320E0C72A1 Q34493341-2B6A0897-079C-437C-A804-693AFA1449C3 Q34498952-76442AD6-785E-4816-A2CE-55EEA6260677 Q34500688-445F5BE2-11D5-442C-BFD9-B40F8BE1CE35 Q34525673-AEED53A7-079B-4797-AE39-9C4835BB75CD Q34551761-90FF673F-0240-42FB-99F6-F187A766A300 Q34553964-DDE9B612-6167-4130-A96A-B0A7642A906F Q34558080-48C9A831-F906-4D69-9A19-81948B702F9F Q34613650-72DCA32F-FFEB-40B8-82F6-B423BE186424

P2860

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis.

http://www.wikidata.org/entity/Q44259982

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Conditional activation of Neu ...... versible pulmonary metastasis.

@en

Conditional activation of Neu ...... versible pulmonary metastasis.

@nl

type

label

Conditional activation of Neu ...... versible pulmonary metastasis.

@en

Conditional activation of Neu ...... versible pulmonary metastasis.

@nl

prefLabel

Conditional activation of Neu ...... versible pulmonary metastasis.

@en

Conditional activation of Neu ...... versible pulmonary metastasis.

@nl

P1433

Q44259982-1779D5AD-F6F3-4F99-89E3-DF6307FB8752

P1476

Q44259982-A98CBB77-7DF3-490C-A146-6A7BCEB839CC

P2093

Q44259982-2265BC3B-0B46-485D-BAE0-DC5AA9C0FD81

Q44259982-24001C0F-199A-4FAE-9615-C1524B27B4C6

Q44259982-2F4589C6-D26E-4E1A-985D-496CAD554F5B

Q44259982-40BF95FC-AF24-4BE8-ABC0-2E589FFBDEC8

Q44259982-45FBC7EF-AFF0-417E-B969-FA4F6F085B53

Q44259982-498B15FB-A597-4A5D-B5B1-4A85A63D9C0E

Q44259982-5D6FC73C-52D3-4B28-A970-F301A5E2A235

Q44259982-748B8D02-16A1-41E1-877D-B5D5C7C25DC0

Q44259982-CA22A79B-B7B5-47A4-95F8-54C97D56CEE1

Q44259982-F4C998CC-CC2F-4AD5-ACF4-E94D2CB08EE7

P304

Q44259982-EB08E788-1F80-4BEA-9C26-D018BE884EEF

P31

Q44259982-EC6BEC48-0563-4048-B9E5-A0B0852B48ED

P356

Q44259982-DC185629-F150-4EBF-8E89-03E7DE25F510

P433

Q44259982-2A53016E-37D4-48DA-BD07-67E9E64B221E

P478

Q44259982-53ED892F-9EBF-4137-85FD-B9D41F332339

P577

Q44259982-D15425E6-DB6B-455F-B679-9E9B591EE177

P698

Q44259982-12D74F64-26CE-4DFF-8F43-9BF87B74E4DD

P356

S1535-6108(02)00212-X

P1433

P1476

Conditional activation of Neu ...... versible pulmonary metastasis.

@en

P2093

Christopher J Sarkisian

http://www.w3.org/2001/XMLSchema#string

Edward J Gunther

http://www.w3.org/2001/XMLSchema#string

Katherine D Dugan

http://www.w3.org/2001/XMLSchema#string

Kristina T Hahn

http://www.w3.org/2001/XMLSchema#string

Lewis A Chodosh

http://www.w3.org/2001/XMLSchema#string

Mitchell D Schnall

http://www.w3.org/2001/XMLSchema#string

Nathalie Innocent

http://www.w3.org/2001/XMLSchema#string

Robert D Cardiff

http://www.w3.org/2001/XMLSchema#string

Steven Pickup

http://www.w3.org/2001/XMLSchema#string

Susan E Moody

http://www.w3.org/2001/XMLSchema#string

P304

451-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1535-6108(02)00212-X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12498714

http://www.w3.org/2001/XMLSchema#string